Immune-Onc Therapeutics raised $73M Series B venture round, led by Dave Chenn.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
| Foundation | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$138M
Top Valuation
-
Immune-Onc Therapeutics raised $73M in a Series B round.
The round was announced on 03/30/21.
The round was led by Dave Chenn.